Joshi Manher has filed 7 insider transactions across 2 companies since August 2023.
Most recent transaction: a grant/award of 4100 shares of SOLENO THERAPEUTICS INC ($SLNO) on January 21, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Joshi Manher | Chief Development Officer | A | Common Stock | 4100 | $0.00 | 20,171.0000 | 54,921,916 | 25.51% | 0.01% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Joshi Manher | Chief Development Officer | A | Employee stock option (right to buy) | 4700 | $0.00 | 4,700.0000 | 54,921,916 | 9999.99% | 0.01% |
| Nov. 10, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Joshi Manher | Chief Development Officer | A | Common Stock | 16071 | $0.00 | 16,071.0000 | 54,921,916 | 9999.99% | 0.03% |
| Nov. 10, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Joshi Manher | Chief Development Officer | M | Employee stock option (right to buy) | 72321 | $0.00 | 72,321.0000 | 54,921,916 | 9999.99% | 0.13% |
| Nov. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Joshi Manher | EVP, Chief Medical Officer | S | Common Stock | 12287 | $0.39 | 171,284.0000 | 0 | 6.69% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Joshi Manher | EVP, Chief Medical Officer | S | Common Stock | 3202 | $1.65 | 187,344.0000 | 0 | 1.68% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Joshi Manher | EVP, Chief Medical Officer | S | Common Stock | 3773 | $1.65 | 183,571.0000 | 0 | 2.01% | 0.00% |